ImmunoGrow

ImmunoGrow is rated 3 out of 5 in the category biotechnology. Read and write reviews about ImmunoGrow. ImmunoGrow is the first cell activation and growth platform purposefully designed for the industrialization of cell-based cancer immunotherapies that will simplify production, reduce costs and enhance patient safety. CAR T Cell therapies represent a generational shift in cancer treatment by employing the body's own immune system to seek out and destroy cancerous cells. In patients with B-Cell leukemias and lymphomas that fail to respond to other types of treatment, up to 80% see their cancer disappear when these treatments are employed. As a participant in the BioExel Accellerator, ImmunoGrow is supported by Enterprise Ireland, Bank of Ireland and the Western Development Commission.